AlphaYou
Overview
Smart money at a glance
Filings to Oct 2, 2026Net selling: insiders sold $4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$4M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- 2 awardsAwards on record
Key stats
Fundamentals Oct 2- Open
- $11.89
- 52-wk high
- $12.93
- High
- $12.47
- 52-wk low
- $5.03
- Low
- $11.83
- Prev close
- $11.85
- Mkt cap
- $510.1M
- Volume
- 414.1K
- Beta
- 0.68
- P/S
- 8.4x
- P/B
- 3.6x
- Profit margin
- -57.0%
- Op margin
- -39.6%
- ROE
- -24.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about MASS filings
Are insiders buying or selling 908 Devices Inc (MASS) stock?
Net selling: insiders sold $4M and bought $0 of MASS stock on the open market in the 90 days to Oct 2, 2026, according to SEC Form 4 filings. $2.5M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Knopp, Kevin J. (President and CEO), who sold $1.8M. The latest filing was on Oct 1, 2026.
Which members of Congress have traded MASS recently?
None. No member of Congress disclosed a MASS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this MASS smart-money data?
This summary uses filings available on Oct 2, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in MASS right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 21.4% above what analysts expected.
Earnings per share
-$0.14 expected
Reports Nov 9, 2026, in 38 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $14.0M | $17.4M | $13.4M | $16.1M |
| Cost of what it sold | $7.1M | $8.7M | $7.0M | $7.7M |
| Gross profit | $6.9M | $8.7M | $6.4M | $8.3M |
| What it spent | ||||
| Research and development | $3.4M | $3.1M | $3.1M | $3.6M |
| Sales and admin | $9.1M | $8.8M | $9.9M | $11.1M |
| Other operating costs | — | — | — | $6.4M |
| Total operating expenses | $12.4M | $11.8M | $12.9M | $21.2M |
| What was left | ||||
| Operating profit | -$5.5M | -$3.2M | -$6.5M | -$12.8M |
| Profit before tax | -$14.9M | $4.3M | -$12.0M | -$11.9M |
| Tax | $29.0K | -$166.0K | — | -$54.0K |
| Net profit | -$14.9M | $4.3M | -$12.0M | -$11.9M |
| EBITDA | -$13.8M | $5.4M | -$10.8M | -$10.6M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace